Inhibition of naive Th1 CD4+ T cells by glatiramer acetate in multiple sclerosis

Author(s): Kantengwa S, Weber MS, Juillard C, Benkhoucha M, Fellay B, et al.


We investigated whether glatiramer acetate (GA) treatment may affect Th1 differentiation at various T-cell maturation stages. Specifically, we analyzed the effect of in vivo GA treatment on intracellular synthesis of IL-2 and TNF-alpha by naive, memory and effector CD4(+) and CD8(+) T cells by five-colour flow cytometry. Our data indicate that GA treatment downregulates/normalizes an accelerated Th1 differentiation of CD4(+) T cells in RRMS patients at all stages of T-cell maturation. Most notably, we conclude that, by altering naive, unprimed CD4(+) T cells, GA treatment appears to affect T-cell differentiation, at least in part, in an antigen-independent manner.

Similar Articles

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

Author(s): Matusevicius D, Kivisäkk P, He B, Kostulas N, Ozenci V, et al.

Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis

Author(s): Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, et al.

Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer

Author(s): Teitelbaum D, Webb C, Bree M, Meshorer A, Arnon R, et al.

The lineage decisions of helper T cells

Author(s): Murphy KM, Reiner SL

Lymphocyte responses and cytokines

Author(s): Paul WE, Seder RA

Mechanisms of action of glatiramer acetate in multiple sclerosis

Author(s): Neuhaus O, Farina C, Wekerle H, Hohlfeld R